Fig. 1From: A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancersCytidine nucleoside (a) and azanucleoside (b, c) chemical structures. Sugar moieties are indicated in grey and chemical changes between cytidine nucleoside and azanucleosides are highlighted in red Back to article page